A total of 656 patients were included during the beta-lactam strategy periods , 739 during the beta-lactam-macrolide strategy periods , and 888 during the fluoroquinolone strategy periods , with rates of adherence to the strategy of 93.0 % , 88.0 % , and 92.7 % , respectively .